Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ ProDots Human IL-6 Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

$729.00 - $1099.00

Specifications

Gene Alias B cell stimulatory factor-2, B-cell differentiation factor, BSF2, BSF-2, BSF2CTL differentiation factor, CDF, HGFHSFIFNB2Hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6B-cell stimulatory factor 2, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A
Source Source: E. coli-derived Pro29 - Met212; N Terminal Sequence: Pro29
Conjugate Unlabeled
Recombinant Yes
Gene ID (Entrez) 3569
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
PRD20610 View Documents R&D Systems™
PRD20610
50μg Each for $729.00
Add to cart
 
PRD20650 View Documents R&D Systems™
PRD20650
250μg Each for $1,099.00
Add to cart
 
Description

Description

The ProDots Recombinant Human IL-6 Protein is derived from E. coli. The ProDots Recombinant Human IL-6 Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

B cell stimulatory factor-2, B-cell differentiation factor, BSF2, BSF-2, BSF2CTL differentiation factor, CDF, HGFHSFIFNB2Hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6B-cell stimulatory factor 2, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A
Unlabeled
3569
Human
IL6
<0.10 EU per 1μg of the protein by the LAL method.
Bioactivity
Source: E. coli-derived Pro29 - Met212; N Terminal Sequence: Pro29
Yes
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Predicted MW: 20.3kDa Observed MW: 21kDa, reducing conditions
Measured in a cell proliferation assay using T1165.85.2.1 mouse plasmacytoma cells. Nordan, R.P. et al. (1987) J. Immunol. 139:813. The ED50 for this effect is typically 0.2-0.8ng/mL.
Q75MH2
E. coli-derived Pro29 - Met212
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit